Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tiliquinol

Copy Product Info
😃Good
Catalog No. T64352Cas No. 5541-67-3
Alias NSC 130828

Tiliquinol (NSC-130828) (NSC-130828) is a non-absorbed luminal agent with anti-amoebic properties that is often used in conjunction with tibroquinol. It is commonly employed in the study and investigation of amebic liver abscesses.

Tiliquinol

Tiliquinol

Copy Product Info
😃Good
Purity: 99.74%
Catalog No. T64352Alias NSC 130828Cas No. 5541-67-3
Tiliquinol (NSC-130828) (NSC-130828) is a non-absorbed luminal agent with anti-amoebic properties that is often used in conjunction with tibroquinol. It is commonly employed in the study and investigation of amebic liver abscesses.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$32In StockIn Stock
50 mg$48In StockIn Stock
100 mg$72In StockIn Stock
500 mg$159-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.74%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Tiliquinol AI Summary
Tiliquinol exhibits a broad spectrum of bioactivities across various assays and models. It has demonstrated the ability to inhibit ROR gamma transcriptional activity, delay death of malarial parasite plastid, support Schwann cell viability, induce DNA re-replication in various cell lines, inhibit human tyrosyl-DNA phosphodiesterase 1, and block entry of both Marburg and Ebola viruses. Additionally, it shows potency as a gametocytocidal compound. Despite its wide-ranging pharmacological effects, it exhibits relatively low potency in assays targeting receptors like DRD1, SLC6A2, and HRH3, as well as enzymes such as ACHE, MAOA, and PTGS1. Moreover, it shows both agonist and antagonist activities at receptors HTR2B and ADRA1A, albeit at low affinity. The compound also has notable effects on liver toxicity, including moderate and acute hepatotoxicity and granulomatous hepatitis, though it is not significantly associated with chronic liver disease or tumors. With a LogP of 2.38, Tiliquinol has moderate hydrophobicity, which, along with its pKa values, suggest it possesses properties that may influence its solubility, permeability, and interaction with biological targets. Specifically, it inhibits liver catechol-O-methyltransferase activity in Sprague-Dawley rats with an IC50 of 44668.36 nM. Overall, while Tiliquinol displays a variety of bioactivities and potential therapeutic effects, its relatively low potency in many of the tested assays warrants further investigation to optimize its pharmacological properties..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Tiliquinol (NSC-130828) (NSC-130828) is a non-absorbed luminal agent with anti-amoebic properties that is often used in conjunction with tibroquinol. It is commonly employed in the study and investigation of amebic liver abscesses.
SynonymsNSC 130828
Chemical Properties
Molecular Weight159.18
FormulaC10H9NO
Cas No.5541-67-3
SmilesCc1ccc(O)c2ncccc12
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 90 mg/mL (565.4 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (20.73 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM6.2822 mL31.4110 mL62.8220 mL314.1098 mL
5 mM1.2564 mL6.2822 mL12.5644 mL62.8220 mL
10 mM0.6282 mL3.1411 mL6.2822 mL31.4110 mL
20 mM0.3141 mL1.5705 mL3.1411 mL15.7055 mL
50 mM0.1256 mL0.6282 mL1.2564 mL6.2822 mL
100 mM0.0628 mL0.3141 mL0.6282 mL3.1411 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tiliquinol | purchase Tiliquinol | Tiliquinol cost | order Tiliquinol | Tiliquinol chemical structure | Tiliquinol formula | Tiliquinol molecular weight